Biofrontera- Warrants (27/10/2026) Profit Margin

Biofrontera- Warrants (27/10/2026) posts a profit margin of -25.66% as of March 2026. That compares with -30.34% in the prior-year period — up 15.4% year over year. That is below the Healthcare sector average of 15.29%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Biofrontera- Warrants (27/10/2026)'s profit margin was -30.34%. The latest reading is -25.66% — a 15.4% year-over-year increase (period ending March 2026). Use the history and growth charts on this page for a longer lookback.

For Healthcare stocks, a profit margin near 15.29% is typical. Biofrontera- Warrants (27/10/2026)'s -25.66% is lower that level. That is roughly 267.8% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Biofrontera- Warrants (27/10/2026)'s profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -25.66% as of March 2026; use YoY and peer views to separate noise from signal.

Context for BFRIW's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 15.29%), and (3) consistency with growth and profitability. This page covers the first two; Biofrontera- Warrants (27/10/2026)'s other metric pages and overview cover the third.